To the Editor: The randomized trial conducted by Méjean et al. questions the role of cytoreductive nephrectomy before systemic therapy in patients with metastatic renal-cell carcinoma.Indeed, at face value, the procedure could be abandoned completely.However, the selection of patients isThe New England
No takes yet. Share an insight, caveat, or question.
Kozlitina et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: